90 related articles for article (PubMed ID: 9180368)
1. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease.
Uemasu J; Nakaoka A; Kawasaki H; Ishikawa I; Yoshino Y; Shio H; Nemoto R; Nakamura I; Morio S
Life Sci; 1997; 60(23):2139-44. PubMed ID: 9180368
[TBL] [Abstract][Full Text] [Related]
2. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Lee KB; Kim UK; Lee CC
J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
[TBL] [Abstract][Full Text] [Related]
3. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
[TBL] [Abstract][Full Text] [Related]
4. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
[TBL] [Abstract][Full Text] [Related]
5. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease.
Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD
Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease.
Schiavello T; Burke V; Bogdanova N; Jasik P; Melsom S; Boudville N; Robertson K; Angelicheva D; Dworniczak B; Lemmens M; Horst J; Todorov V; Dimitrakov D; Sulowicz W; Krasniak A; Stompor T; Beilin L; Hallmayer J; Kalaydjieva L; Thomas M
Nephrol Dial Transplant; 2001 Dec; 16(12):2323-7. PubMed ID: 11733623
[TBL] [Abstract][Full Text] [Related]
7. Influence of angiotensin converting enzyme (
Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
[TBL] [Abstract][Full Text] [Related]
8. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
[TBL] [Abstract][Full Text] [Related]
9. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease.
van Dijk MA; Breuning MH; Peters DJ; Chang PC
Nephrol Dial Transplant; 2000 Jun; 15(6):836-9. PubMed ID: 10831637
[TBL] [Abstract][Full Text] [Related]
10. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease.
van Dijk MA; Peters DJ; Breuning MH; Chang PC
J Am Soc Nephrol; 1999 Sep; 10(9):1916-20. PubMed ID: 10477143
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE.
Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH
Lupus; 2002; 11(4):227-33. PubMed ID: 12043886
[TBL] [Abstract][Full Text] [Related]
13. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Ecder T; McFann KK; Raynolds MV; Schrier RW
Am J Nephrol; 2003; 23(6):466-70. PubMed ID: 14600431
[TBL] [Abstract][Full Text] [Related]
14. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD).
Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W
Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958
[No Abstract] [Full Text] [Related]
15. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
[TBL] [Abstract][Full Text] [Related]
16. The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney disease.
Wanic-Kossowska M; Posnik B; Kobelski M; Pawliczak E; Pawlaczyk K; Hoppe K; Schwermer K; Sikorska D
ScientificWorldJournal; 2014; 2014():707658. PubMed ID: 24672357
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of ACE DD genotype among north Indian end stage renal disease patients.
Tripathi G; Dharmani P; Khan F; Sharma RK; Pandirikkal V; Agrawal S
BMC Nephrol; 2006 Oct; 7():15. PubMed ID: 17042963
[TBL] [Abstract][Full Text] [Related]
18. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
Zivko M; Kusec R; Galesić K
Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
Jacobsen P; Rossing K; Rossing P; Tarnow L; Mallet C; Poirier O; Cambien F; Parving HH
Kidney Int; 1998 Apr; 53(4):1002-6. PubMed ID: 9551410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
